OTX015 5mg 5mg | Purity Not Available
Adooq Bioscience
OTX015 is an orally bioavailable, small molecule inhibitor of BRD2, BRD3, and BRD4 (EC50s = 10-19 nM).
More Information Supplier PageOTX015 is an orally bioavailable, small molecule inhibitor of BRD2, BRD3, and BRD4 (EC50s = 10-19 nM).
More Information Supplier PageOTX015 is an orally bioavailable, small molecule inhibitor of BRD2, BRD3, and BRD4 (EC50s = 10-19 nM).
More Information Supplier PageOTX015 is an orally bioavailable, small molecule inhibitor of BRD2, BRD3, and BRD4 (EC50s = 10-19 nM).
More Information Supplier PageOTX015 is an orally bioavailable, small molecule inhibitor of BRD2, BRD3, and BRD4 (EC50s = 10-19 nM).
More Information Supplier PageTP-434 is a novel, broad-spectrum fluorocycline antibiotic with activity against bacteria expressing major antibiotic resistance mechanisms including tetracycline-specific efflux and ribosomal-protection.
More Information Supplier PageTP-434 is a novel, broad-spectrum fluorocycline antibiotic with activity against bacteria expressing major antibiotic resistance mechanisms including tetracycline-specific efflux and ribosomal-protection.
More Information Supplier PageAfzelin is a flavonol glycoside. It is the rhamnoside of kaempferol. It is found in Nymphaea odorata.
More Information Supplier PageAfzelin is a flavonol glycoside. It is the rhamnoside of kaempferol. It is found in Nymphaea odorata.
More Information Supplier Page